Explore 3 Stock Ideas & Industry Insights Download Free Report

Ramsay Health Care Ltd

Company price
55.75 AUD -0.26 ( 0.46%)
Last update at 2026-11-06T06:17:00Z
VOLUME
524515
Market Cap
12928.78M
P/E
41.18

Momentum Score

…

Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
55.50
Low
56.25
High
52 Week Price Range
29.82
Low
56.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Ramsay Health Care is a multinational private hospital operator delivering acute, surgical and ancillary health services through a network of hospitals and clinics. Long-term growth may be supported by aging populations and rising demand for elective and specialist procedures, together with organic capacity growth and selective acquisitions. Investors may find the company attractive for its scale, recurring inpatient and outpatient revenue streams and exposure to defensive healthcare demand.
Key risks include exposure to regulatory and reimbursement changes, cost and staffing pressures that can compress margins, and execution and integration risk from expansion into new markets.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
56.01
Dividend Yield
1.65%
Revenue TTM
18649.10M
Revenue Per Share
81.01
Gross Profit TTM
2284.60M
Debt / Equity
2.22
ROE
5.69%
Net Debt
10268.60M
ROCE
5.93%
Diluted EPS TTM
1.36

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 513.60M 101.80M 384.60M 527.10M 538.50M
Minority interest - -22.30M 7.30M -67.40M -105.20M
Net income 329.20M 24.00M 888.70M 298.10M 274.00M
Selling general administrative - 11040.20M 10323.50M 9431.00M 8309.50M
Selling and marketing expenses - - 9649.70M - -
Gross profit 1772.40M 2115.20M 1610.70M 11515.30M 9974.30M
Reconciled depreciation - 1126.30M 1082.10M 989.10M 927.60M
Ebit 1014.90M 1034.30M 724.10M 800.00M 696.60M
Ebitda 2196.10M 1592.80M 1806.20M 1789.10M 1624.20M
Depreciation and amortization 1181.20M 558.50M 1082.10M 989.10M 927.60M
Operating income 1014.90M 2115.20M 936.90M 660.30M 460.90M
Other operating expenses 17562.90M 15676.40M 15727.00M 12671.70M 11411.40M
Interest expense 608.40M 621.80M 620.00M 261.20M 146.80M
Tax provision - 55.50M 121.30M 181.50M 159.30M
Interest income - 17.40M 7.00M 514.30M 36.20M
Net interest income - -604.40M -613.00M -474.30M -352.80M
Extraordinary items - 0.00M 618.10M 19.90M 8.10M
Income tax expense 192.20M 55.50M 121.30M 181.50M 159.30M
Total revenue 18577.80M 17791.60M 16660.20M 14863.00M 13082.10M
Total operating expenses 757.50M 728.50M 12013.60M 10961.10M 9743.70M
Cost of revenue 16805.40M 15676.40M 3713.40M 3347.70M 3107.80M
Total other income expense net -501.30M -2013.40M -552.30M 447.20M 660.70M
Discontinued operations - - - 19.90M 15.30M
Net income from continuing ops - 46.30M 263.30M 345.60M 379.20M
Net income applicable to common shares - 6.80M 872.00M 285.10M 265.00M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 21170.20M 22475.50M 21342.40M 21030.20M 19473.30M
Intangible assets 398.30M 424.90M - 407.30M 435.20M
Other current assets 290.30M 48.80M 308.50M 28.30M 24.50M
Total liab 15576.40M 16766.80M 15814.90M 16207.00M 14947.10M
Total stockholder equity 4956.00M 5023.60M 4897.60M 4154.80M 3933.50M
Other current liab 2005.20M - 1827.20M 2326.10M 2264.10M
Common stock 2285.90M - 2246.80M 2148.60M 2125.20M
Capital stock - 2482.40M - 2400.80M 2377.40M
Retained earnings 2457.30M 2328.70M 2500.20M 1786.70M 1708.70M
Other liab - - - 997.10M 920.40M
Good will 5577.20M 6006.20M 5744.90M 5756.40M 5363.80M
Other assets - - - 719.00M 669.20M
Cash 729.90M 784.40M 662.30M 656.10M 314.20M
Cash and equivalents - - - - 314.20M
Total current liabilities 4065.70M 4465.60M 4180.30M 3810.40M 3725.60M
Current deferred revenue - - 95.60M -486.80M -412.10M
Net debt 10268.60M 4752.50M 10275.80M 11230.20M 10384.50M
Short term debt 628.30M - 605.70M 486.80M 397.60M
Short long term debt - 78.50M - 69.90M 42.80M
Short long term debt total 10998.50M - 10938.10M 11886.30M 10698.70M
Other stockholder equity -39.40M - 2183.80M -4003.10M -3906.30M
Property plant equipment - - - 10187.20M 9434.60M
Total current assets 3704.90M 4040.30M 3872.80M 3895.80M 3286.70M
Long term investments - 110.80M - 83.60M 338.90M
Net tangible assets - - - -2261.10M -2117.70M
Short term investments - - - 64.50M 11.30M
Net receivables 2281.50M 2701.50M 2522.60M 2266.90M 2331.30M
Long term debt - 5458.40M - 5861.50M 5173.50M
Inventory 403.20M 404.40M 379.40M 388.60M 376.80M
Accounts payable 1432.20M 1728.10M 1651.80M 1484.30M 1476.00M
Accumulated other comprehensive income - - -2285.40M -32.70M -152.60M
Non currrent assets other 132.20M 10.40M 475.70M 256.20M 135.40M
Non current assets total 17465.30M 18435.20M 17469.60M 17134.40M 16186.60M
Capital lease obligations - 6583.00M - 5954.90M 5482.40M
Long term debt total - - - - 10301.10M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -765.30M 159.70M -713.80M 30.00M
Change to liabilities - - - 102.80M 124.70M
Total cashflows from investing activities -675.00M -765.30M 159.70M -713.80M 30.00M
Net borrowings - 93.20M -825.40M -3.60M -1037.80M
Total cash from financing activities -789.00M -631.20M -1450.10M -242.40M -1410.90M
Change to operating activities - - - -89.20M -31.80M
Net income 329.20M 24.00M 270.60M 298.10M 274.00M
Change in cash -54.50M 122.10M 6.20M 341.90M -690.60M
Begin period cash flow 784.40M 662.30M 656.10M 314.20M 1004.80M
End period cash flow 729.90M 784.40M 662.30M 656.10M 314.20M
Total cash from operating activities 1442.10M 1480.80M 1292.80M 1279.60M 715.50M
Depreciation 1181.20M 1126.30M 1082.10M 962.30M 906.90M
Other cashflows from investing activities 62.30M 36.90M 16.10M 7.10M 1972.20M
Dividends paid 205.70M -161.60M -158.30M -236.80M -371.00M
Change to inventory -20.80M -4.20M 17.50M -14.20M 28.20M
Change to account receivables 65.00M 157.90M -264.50M 118.20M -664.80M
Other cashflows from financing activities -632.00M -54.00M -466.40M 2463.60M 4733.50M
Change to netincome - - - -32.20M 72.70M
Capital expenditures 734.20M 776.60M 753.80M 720.90M 708.50M
Change in working capital -36.70M 56.00M -48.70M 104.00M -636.60M
Stock based compensation - 10.70M - 8.00M 13.00M
Other non cash items -31.60M 263.80M 1070.90M 19.20M -465.40M
Free cash flow 707.90M 704.20M 539.00M 558.70M 7.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RHC
Ramsay Health Care Ltd
-0.26
0.46%
55.75 41.18 31.85 0.69 2.57 1.25 11.44
RHCPA
Ramsay Health Care Ltd
-0.05
0.05%
106.81 65.76 - 0.77 - - -
REG
Regis Healthcare Ltd
-0.07
1.38%
5.01 28.22 28.90 1.14 259.34 0.99 4.39
RYM
Ryman Healthcare Limited
-
-%
1.44 - - 1.71 0.70 6.49 -
SNZ
Summerset Group Holdings Ltd
-0.16
3.09%
5.02 4.80 5.25 3.15 0.46 18.77 19.38

Profile*

Ramsay Health Care Ltd

Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.

Level 7, Tower B, St Leonards, NSW, Australia, 2065

61 2 9433 3444

91400

Name Title Year Born
Mr. Craig Ralph McNally CEO, MD & Exec. Director 1961
Mr. Martyn J. Roberts Group Chief Financial Officer 1968
Ms. Kelly Hibbins Group Head of Investor Relations NA
Ms. Henrietta Rowe BECON, L.L.B. Group Gen. Counsel & Company Sec. NA
Ms. Colleen Harris Group Chief People Officer 1969
Mr. Andrew Wearne Global Chief Audit Exec. NA
Dr. Andrew Jones Group Chief Growth Officer 1974
Sir Edward Byrne AC, DSc, FMEDSCI, FRACP, FRCP, FTSE, M.D., MBA Group Chief Medical Officer 1952
Mr. Kah Peng Hong Group Chief Exec. Officer of Ramsay Sime Darby Health Care 1973
Doug Meagher CFO of Ramsay Australia NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…